These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 9543473)

  • 1. What new antibiotics to offer in the outpatient setting.
    Fraser KL; Grossman RF
    Semin Respir Infect; 1998 Mar; 13(1):24-35. PubMed ID: 9543473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrolides are ideal for empiric therapy of community-acquired pneumonia in the immunocompetent host.
    Vergis EN; Yu VL
    Semin Respir Infect; 1997 Dec; 12(4):322-8. PubMed ID: 9436959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current antibiotics for clinical practice].
    Zimmerli W
    Praxis (Bern 1994); 1996 Oct; 85(40):1240-4. PubMed ID: 8966413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Empiric therapy of community-acquired pneumonia: a transatlantic controversy].
    Garin N; Nendaz M
    Rev Med Suisse; 2006 Jan; 2(50):289-90, 292-4. PubMed ID: 16503046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Principles of antibiotic treatment of community-acquired pneumonia in the outpatient setting.
    Segreti J; House HR; Siegel RE
    Am J Med; 2005 Jul; 118 Suppl 7A():21S-28S. PubMed ID: 15993674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approach to therapy of respiratory infections in the critical care setting.
    Pennington JE
    Semin Respir Infect; 1990 Sep; 5(3):226-32. PubMed ID: 2255806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outpatient treatment of community-acquired pneumonia in adults.
    Pomilla PV; Brown RB
    Arch Intern Med; 1994 Aug; 154(16):1793-802. PubMed ID: 8053746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.
    Feldman C
    J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotics for community-acquired pneumonia.
    Dryden M; Hand K; Davey P;
    J Antimicrob Chemother; 2009 Dec; 64(6):1123-5. PubMed ID: 19820250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
    Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Community-acquired pneumonia in children].
    Gendrel D; Moulin F
    Rev Prat; 2007 Nov; 57(17):1883-94. PubMed ID: 18095624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empiric antibiotic prescribing for patients with community-acquired pneumonia: where can we improve?
    Buising KL; Thursky KA; Black JF; Macgregor L; Street AC; Kennedy MP; Brown GV
    Intern Med J; 2008 Mar; 38(3):174-7. PubMed ID: 18290813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community-acquired pneumonia.
    Bartlett JG
    Int J Clin Pract Suppl; 2000 Dec; (115):18-22. PubMed ID: 11219294
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibiotic treatment of community acquired pneumonia varies widely across Germany.
    Kohlhammer Y; Raspe H; Marre R; Suttorp N; Welte T; Schäfer T;
    J Infect; 2007 May; 54(5):446-53. PubMed ID: 17007933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outpatient treatment of community-acquired pneumonia: evolving trends and a focus on fluoroquinolones.
    Carrie AG; Kozyrskyj AL
    Can J Clin Pharmacol; 2006; 13(1):e102-11. PubMed ID: 16585811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers to the effective management of respiratory tract infections in the community.
    Saginur R
    Infection; 2001 Dec; 29 Suppl 2():3-10. PubMed ID: 11785853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial class is not obviously important in outpatient pneumonia: a meta-analysis.
    Maimon N; Nopmaneejumruslers C; Marras TK
    Eur Respir J; 2008 May; 31(5):1068-76. PubMed ID: 18216053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumonia observational incidence and treatment: a multidisciplinary process improvement study.
    Brozek J; McDonald E; Clarke F; Gosse C; Jaeschke R; Cook D
    Am J Crit Care; 2007 May; 16(3):214-9. PubMed ID: 17460312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of gemifloxacin in community-acquired pneumonia.
    Tillotson GS
    Expert Rev Anti Infect Ther; 2008 Aug; 6(4):405-18. PubMed ID: 18662107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in guidelines for the therapy of non-nosocomial pneumonitis].
    Navazio F
    Clin Ter; 2000; 151(1):25-7. PubMed ID: 10822878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.